Get research updatesAnxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.
Effect of Hormones on Response to Exposure Therapy for Social Anxiety Disorder
This study has finished and is no longer accepting participants.
In AustinThis study has finished and is no longer accepting participants.
In Baton RougeIntegrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression in Denmark (the Danish IBBIS Study): A Multi-center Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In Copenhagen
Differential Efficacy of Memantine for Obsessive-compulsive Disorder vs. Generalized Anxiety Disorder: an Open-label Trial
This study has finished and is no longer accepting participants.
In Los AngelesDevelopment of Mindfulness Through Adaptive Biofeedback Methods in the Treatment of Anxiety Disorders: Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In Moscow
A Novel Mechanism-Based Treatment for Pediatric Anxiety Disorders
This study has finished and is no longer accepting participants.
In St LouisResearchers are studying PH94B, tracking side effects to assess safety and tolerability in adults with an anxiety condition.
This study ended early.
Multiple locations, including WatertownA Phase 3b, Randomized, Double-blind, 8-week, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Centanafadine Once Daily Extended-release Capsules for the Treatment of Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety
This study has finished and is no longer accepting participants.
Multiple locations, including DothanThis study has finished and is no longer accepting participants.
In CharlestonA Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of PH94B Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesA US, Phase 3 Multicenter, Randomized, Double-blind, Placebo Controlled Trial of PH94B Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder (PaliSADe-2)
This study ended early.
Multiple locations, including PhoenixThis study has finished and is no longer accepting participants.
Multiple locations, including MinneapolisWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.